|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
ZICONOTIDE |
N02BG08 |
PT
|
POM
|
|
|
|
VALID
|
|
ZIDOVUDINE AND LAMIVUDINE |
J05AR01 |
PT
|
Currently not available
|
|
PT/H/0972/001/DC |
25-07-2013 |
VALID
|
|
ZINC GLUCONATE |
A12CB02 |
PT
|
Not authorised
|
|
|
|
VALID
|
|
ZINC PRODUCTS |
D02AB |
PT
|
Not subject to prescription
|
|
None |
|
VALID
|
|
ZIPEPROL |
R05DB15 |
PT
|
Not authorised
|
|
|
|
VALID
|
|
ZOLEDRONIC ACID |
M05BA08 |
PT
|
Currently not available
|
|
PT/H/1243/002/ |
06-05-2015 |
VALID
|
|
ZOLMITRIPTAN |
N02CC03 |
PT
|
I
|
|
None |
|
VALID
|
|
ZOLPIDEM |
N05CF02 |
PT
|
Currently not available
|
|
PT/H/0481/002/ |
17-02-2014 |
VALID
|
|
ZOMEPIRAC |
M01AB04 |
PT
|
Not authorised
|
|
|
|
VALID
|
|
ZOTEPINE |
N05AX11 |
PT
|
Currently not available
|
|
PT/H/0596/003/ |
27-02-2013 |
VALID
|
|
BILASTINE |
R06AX29 |
PT
|
POM
|
21-03-2025 |
|
|
VALID
|
|
HYDROCORTISONE |
H02AB09 |
PT
|
POM
|
10-01-2025 |
|
|
VALID
|
|
IRBESARTAN AND DIURETICS |
C09DA04 |
PT
|
POM
|
10-01-2025 |
PT/H/0637/003/ |
21-06-2012 |
VALID
|
|
LOSARTAN AND DIURETICS |
C09DA01 |
PT
|
POM
|
10-01-2025 |
PT/H/1010/002/DC |
30-07-2013 |
VALID
|
|
PARICALCITOL |
H05BX02 |
PT
|
POM
|
10-01-2025 |
PT/H/0450/002/ |
05-01-2015 |
VALID
|
|
DROTAVERINE |
A03AD02 |
PT
|
Not authorised
|
09-01-2025 |
|
|
VALID
|
|
ESTRIOL |
G03CA04 |
PT
|
POM
|
20-12-2024 |
|
|
VALID
|
|
ROSUVASTATIN, AMLODIPINE AND PERINDOPRIL |
C10BX14 |
PT
|
Not authorised
|
16-12-2024 |
|
|
VALID
|
|
ATORVASTATIN, ACETYLSALICYLIC ACID AND RAMIPRIL |
C10BX06 |
PT
|
POM
|
12-12-2024 |
|
|
VALID
|
|
ATORVASTATIN AND AMLODIPINE |
C10BX03 |
PT
|
POM
|
11-12-2024 |
PT/H/1094/002/ |
02-07-2014 |
VALID
|
|
BEMPEDOIC ACID AND EZETIMIBE |
C10BA10 |
PT
|
Not authorised
|
10-12-2024 |
EMEA/H/C/004959 |
27-03-2020 |
VALID
|
|
ROSUVASTATIN AND EZETIMIBE |
C10BA06 |
PT
|
POM
|
10-12-2024 |
|
|
VALID
|
|
VOLANESORSEN |
C10AX18 |
PT
|
POM
|
10-12-2024 |
|
|
VALID
|
|
ALIROCUMAB |
C10AX14 |
PT
|
POM
|
09-12-2024 |
EMEA/H/C/003882 |
23-09-2015 |
VALID
|
|
BEMPEDOIC ACID |
C10AX15 |
PT
|
POM
|
09-12-2024 |
EMEA/H/C/004958 |
01-04-2020 |
VALID
|
|
EVOLOCUMAB |
C10AX13 |
PT
|
POM
|
09-12-2024 |
|
|
VALID
|
|
EZETIMIBE |
C10AX09 |
PT
|
POM
|
09-12-2024 |
|
|
VALID
|
|
ACIPIMOX |
C10AD06 |
PT
|
Not authorised
|
06-12-2024 |
|
|
VALID
|
|
CIPROFIBRATE |
C10AB08 |
PT
|
Not authorised
|
05-12-2024 |
PT/H/0575/001/DC |
19-07-2013 |
VALID
|
|
COLESTYRAMINE |
C10AC01 |
PT
|
POM
|
05-12-2024 |
|
|
VALID
|
|
ATORVASTATIN |
C10AA05 |
PT
|
POM
|
04-12-2024 |
PT/H/0347/004/ |
24-04-2015 |
VALID
|
|
PITAVASTATIN |
C10AA08 |
PT
|
POM
|
04-12-2024 |
|
|
VALID
|
|
ROSUVASTATIN |
C10AA07 |
PT
|
POM
|
04-12-2024 |
PT/H/1127/004/ |
18-07-2014 |
VALID
|
|
SIMVASTATIN |
C10AA01 |
PT
|
POM
|
04-12-2024 |
|
|
VALID
|
|
LOVASTATIN |
C10AA02 |
PT
|
POM
|
03-12-2024 |
|
|
VALID
|
|
PRAVASTATIN |
C10AA03 |
PT
|
POM
|
03-12-2024 |
PT/H/0674/003/ |
11-07-2012 |
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005431 |
21-03-2024 |
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
MARIBAVIR |
J05AX10 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
ADAGRASIB |
L01XX77 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
ASCIMINIB |
L01EA06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005605 |
25-08-2022 |
VALID
|
|
ATIDARSAGENE AUTOTEMCEL |
A16AB21 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005321 |
17-12-2020 |
VALID
|
|
ATOGEPANT |
N02CD07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005871 |
11-08-2023 |
VALID
|
|
AVACOPAN |
L04AJ05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
|
AZTREONAM AND BETA-LACTAMASE INHIBITOR |
J01DF51 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006113 |
22-04-2024 |
VALID
|